New cell attachment peptide sequences from conserved epitopes in the carboxy termini of fibrinogen

Experimental Cell Research

Volumn 287, Issue 1, 2003, Pages 116-129

  Gorodetsky, Raphael ^a   Vexler, Akiva ^a   Shamir, Meir ^a   An, Jianqiang ^a   Levdansky, Lilia ^a   Shimeliovich, Irina ^a   Marx, Gerard ^b  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^b HAPTO Biotech Ltd   (Israel)

Author keywords

Cell uptake; Cell binding; Chemotaxis; Fibrin(ogen); Fibrinopeptides; Haptides; Haptotaxis

Indexed keywords

ANTIBODY; BETA1 INTEGRIN; EPITOPE; FIBRINOGEN; INTEGRIN; PROTEIN SUBUNIT; SEPHAROSE;

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; BINDING AFFINITY; CARBOXY TERMINAL SEQUENCE; CELL ADHESION; CELL LINE; CELL PROLIFERATION; CONTROLLED STUDY; COVALENT BOND; ENDOTHELIUM CELL; FIBROBLAST; HUMAN; HUMAN CELL; MESENCHYME; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; SMOOTH MUSCLE FIBER;

EID: 0038205329     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-4827(03)00120-4     Document Type: Article

References (53)

1. Nieuwenhuizen W., Mosesson M.W., DeMaat M.P.M. Fibrinogen Workshop. Ann. N.Y. Acad. Sci. 936:2001;28-43.
2. Grieninger G. Contribution of the αE C domain to the structure and function of fibrinogen-420. Ann. N.Y. Acad. Sci. 936:2001;44-64.
3. Grieninger G., Lu X., Cao Y., Fu Y., Kudryk B.J., Galanakis D.K., Hertzberg K.M. Fib 420, a novel fibrinogen subclass newborn levels are higher than adult . Blood. 90:1997;2609-2614.
4. Everse S.J., Spraggon G., Doolittle R.F. A three-dimensional consideration of variant human fibrinogens. Thromb. Haemost. 80:(1):1998;1-9.
5. Marx G. Modelling cation-driven (proto)fibrin coagulation. Biopolymers. 27:1998;763-774.
6. Mosesson M.W., Siebenlist K., Meh D.A. The structure and biological features of fibrinogen and fibrin. Ann. N.Y. Acad. Sci. 936:2001;11-36.
7. Murakawa M., Okamura T., Kamura T., Shibuya T., Harada M., Niho Y. Diversity of primary structures of the carboxy-terminal regions of mammalian fibrinogen Aa-chains. Thromb. Haemost. 69:1993;351-360.
8. Olexa S.A., Budzynski A.Z. Localization of a fibrin polymerization site. J. Biol. Chem. 256:1981;3544-3549.
9. Yakovlev S., Litvinovich S., Loukinov D., Medved L. Role of the β-strand insert in the central domain of the fibrinogen γ-module. Biochemistry. 39:2000;15721-15729.
10. Bini A., Itoh Y., Kudryk B.J., Nagase H. Degradation of cross-linked fibrin by metalloproteinase 3 (stromelysisn 1) by hydrolysis of the γ Gly-Ala 405 peptide bond. Biochemistry. 35:1996;13056-13063.
11. Senior R.M., Skogen W.F., Griffin G.L., Wilner G.D. Effects of fibrinogen derivatives upon the inflammatory response studies with human fibrinopeptide . Br. J. Clin. Invest. 77:1986;1014-1019.
12. Wright S.D., Weitz J.I., Huang A.J., Levin S.M., Silverstein S.C., Loike J.D. Complement receptor type three (CD11b/CD18) of human polymorphonuclear leukocytes recognizes fibrinogen. Proc. Natl. Acad. Sci. USA. 85:1988;7734-7738.
13. Altieri D.C., Plescia J., Plow E.F. The structural motif glycine 190-valine 202 of fibrinogen γ chain interacts with the CD11b/CD18 integrin (aMb2, Mac-1) and promotes leukocyte adhesion. J. Biol. Chem. 268:1993;1847-1853.
14. Richardson D.L., Pepper B., Kay A.B. Chemotaxis for human monocytes by fibrinogen-derived peptides. Am. J. Hematol. 52:1976;507-513.
15. Berliner S., Fuchs J., Seligsohn U., Kariv N., Hazaz B., Rotenberg Z., Weinberger I., Agmon J., Pinkhas J., Aronson M. Possible role of fibrinogen in the aggregation of white blood cells. Thromb. Haemost. 58:1987;749-752.
16. Yee K.O., Rooney M.M., Giacelli C.M., Lord S.T., Schwartz S.M. Role of β1 and β3 in human smooth muscle cell adhesion to and contraction of fibrin clots in-vitro. Circ. Res. 83:1998;241-251.
17. Brown L.F., Lanir N., McDonagh J., Tignazzi K., Dvorak A.M., Dvorak H.F. Fibroblast migration in fibrin gel matrices. Am. J. Pathol. 142:1993;273-283.
18. Chalupowicz D.G., Chowdhury I.A., Bach T.L., Barsigian C., Martinez J. Fibrin II induces endothelial cell capillary tube formation. J. Cell Biol. 130:1995;207-215.
19. Gorodetsky R., Vexler A., An J., Mou X., Marx G. Chemotactic and growth stimulatory effects of fibrin(ogen) and thrombin on cultured fibroblasts. J. Lab. Clin. Med. 131:1998;269-280.
20. Gorodetsky R., An J., Clark R.A.F., Gailit J., Levdansky L., Vexler A., Berman E., Marx G. Fibrin microbeads (FMB) as biodegradable carriers for culturing cells and for accelerating wound healing. J. Invest. Dermatol. 112:1999;866-872.
21. Gray A.J., Bishop J.E., Reeves J.T., Laurent G.J. Aα and Bβ chains of fibrinogen stimulate proliferation of human fibroblasts. J. Cell. Sci. 104:1993;409-413.
22. Saldeen T. Vasoactive peptides derived from degradation of fibrinogen and fibrin. Ann. N.Y. Acad. Sci. USA. 408:1983;424-431.
23. Veklich Y., Francis C.W., White J., Weisel J.W. Structural studies of fibrinolysis by electron microscopy. Blood. 92:1998;4721-4729.
24. Marx G. Fibrinogen fragmentation by free radicals coagulation of fibrinogen with Cu(II) and ascorbate . Ricklis E. Radiation Biology. 1990;691-698 Wiley-VCH, Weinheim.
25. Marx G. Immunological monitoring of Fenton fragmentation of fibrinogen. Free Rad. Res. Commun. 12:1991;517-520.
26. Cheresh D.A., Berliner S.A., Vicente V., Ruggeri Z.M. Recognition of distinct adhesive sites on fibrinogen by related integrins on platelets and endothelial cells. Cell. 58:1989;945-953.
27. Farrell D.H., Thiagarajan P., Chung D.W., Davie E.W. Role of fibrinogen α and γ chain sites in platelet aggregation. Proc. Natl. Acad. Sci. USA. 89:1992;10729-10732.
28. Hantgan R.R., Endenburg S., Cavero I., Marguerie G., Uzan A., Sixma J.J., de Groot P.G. Inhibition of platelet adhesion to fibrin(ogen) in flowing whole blood by RGD and fibrinogen γ-chain carboxy terminal peptides. Thromb. Haemost. 68:1992;694-700.
29. Savage B., Bottini E., Ruggeri Z.M. Interaction of integrin alpha IIb beta with multiple fibrinogen domains during platelet adhesion. J. Biol. Chem. 270:1995;28812-28817.
30. Yokoyama K., Zhang X.P., Medved L., Takada Y. Specific binding of integrin αvβ3 to the fibrinogen α and αE chain C-terminal domains. Biochemistry. 38:1999;5872-5877.
31. Suehiro K., Gailit G., Plow E.F. Fibrinogen is a ligand for integrin α5β1 in endothelial cells. J. Biol. Chem. 272:1997;5360-5366.
32. Farrell D.H., Al-Mondhiry H.A. Human fibroblast adhesion to fibrinogen. Biochemistry. 36:1997;1123-1128.
33. Altschul S.F., Madden T.L., Schäffer A.A., Zhang J., Zhang Z., Miller W., Lipman D.J. Gapped BLAST and PSI-BLAST a new generation of protein database search programs . Nucleic Acids Res. 25:1997;3389-3402.
34. Thiagrajan P., Rippon A.J., Farrell D.H. Alternative adhesion sites in human fibrinogen for vascular endothelial cells. Biochemistry. 35:1996;4169-4175.
35. Smith R.A., Rooney M.M., Lord S.T., Mosesson M.W., Gartner T.K. Evidence for new endothelial cell binding sites on fibrinogen. Thromb. Haemost. 84:2000;819-825.
36. Browder T., Folkman J., Prie-Shepherd S.R.M., Skogen W.F., Griffin G.L., Wilner G.D. Effects of fibrinogen derivatives upon the inflammatory response studies with human fibrinopeptide . Br. J. Clin. Invest. 77:2000;1014-1019.
37. Valenuela R., Shainoff J.R., DiBello P.M., Urbanic D.A., Anderson J.M., Matsueda G.R., Kudryk B.J. Immuno-electrophoretic and immuno-histochemical characterizations of fibrinogen derivatives in atherosclerotic aortic intimas and vascular prosthesis pseudo-intimas. Am. J. Pathol. 141:1992;861-880.
38. Horrigan F.T., Degen J.L., Lawn R.M. Fibrinogen deficiency reduces vascular accumulation of apolipoprotein(a) and the development of atherosclerosis in apolipoprotein(a) transgenic mice. Proc. Natl. Acad. Sci. USA. 95:1998;12591-12595.
39. Nagy J.A., Meyers M.S., Masse E.M., Herzberg K.T., Dvorak H.F. Pathogenesis of ascites tumor growth fibrinogen influx and fibrin accumulation in tissues lining the peritoneal cavity . Cancer Res. 55:1995;369-375.
40. Bardos H., Molnar P., Csecsei G., Adany R. Fibrin deposition in primary and metastatic human brain tumors. Blood Coagul. Fibrinol. 7:1996;536-548.
41. Boukamp P., Petrusevska R.T., Breitkreutz D., Hornung J., Markham A., Fusenig N.E. Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. J. Cell Biol. 106:1988;761-771.
42. Geiger B., Bershadsky A., Pankov R., Yamada K. Transmenbrane extracellular matrix - cytosheleton crosstalk. Nat. Rev. Mol. Cell Biol. 2:2002;793-805.
43. Gailit J., Clarke C., Dawn N., Tonnesen M.G., Mosesson M.W., Clark R.A.F. Human fibroblasts bind directly to fibrinogen at RGD sites through integrin αvβ3. Exp. Cell Res. 232:1997;126-181.
44. Schwarze S.R., Ho A., Vocero-Akbani A., Dowdy S.F. In vivo protein transduction delivery of a biologically active protein into the mouse . Science. 285:1999;1569-1572.
45. Vives E., Brodin P., Lebleu B. Truncated HIV-1 tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus. J. Biol. Chem. 272:1997;16010-16017.
46. Sereda T.J., Mant C.T., Sonnichsen F.D., Hodges R.S. Reversed-phase chromatography of synthetic amphiphilic alpha-helical peptides as a model for ligand/receptor interactions effect of changing hydrophobic environment on the relative hydrophilicity/hydrophobicity of amino acid side-chains . J. Chromatogy. 676:1994;139-153.
47. Morris, M.C., Vidal, P.L., Chaloin, Heitz, F., Divita, G. A new peptide vector for efficient delivery of oligonucleotides into mammalian cells. Nucleic Acids Res. 25 (1997) 2730-2736.
48. Derossi D., Joliot A.H., Chassaing G., Prochiantz A. The third helix of the Antennapedia homeodomain translocates through biological membranes. J. Biol. Chem. 269:1994;10444-10450.
49. Mandell A.J., Selz K.A., Shlesinger M.F. Mode matches and their locations in the hydrophobic free energy sequences of peptide ligands and their receptor functions. Proc. Natl. Acad. Sci. USA. 94:1997;13576-13581.
50. Bardos H., Juhasz A., Repassy G., Adany R. Fibrin deposition in squamous cell carcinomas of the larynx and hypopharynx. Thromb. Haemost. 80:1998;767-772.
51. Milev P., Fischer D., Harig M., Schulthess T., Margolis R.K., Chicket-Ehrismann R., Margolis R.U. The fibrinogen like globe of tenascin-C mediates its interactions with neurocan and phophacan/protein-tyrosine phosphatase-ξβ J. Biol. Chem. 272:1997;15501-15509.
52. Schenk S., Chiquet-Ehrismann R., Battegy E.J. The fibrinogen-globe of tenascin-C promotes basic-FGF-induced endothelial cell elongation. Mol. Biol Cell. 10:1999;2933-2943.
53. Lafleur D.W., Chiang J., Fagin J.A., Schwartz S.M., Shah P.K., Wallner K., Forrester J.S., Sharifi B.G. Aortic smooth muscle cells interact with tenascin-C through its fibrinogen-like domain. J. Biol. Chem. 272:1997;32798-32803.